18F-FDG PET/MRI中示踪剂剂量减少的模拟:对肿瘤学判读、图像质量和伪影的影响
该回顾性研究模拟19例患者全身18F-FDG PET/MRI从3至0.5 MBq/kgBW的阶梯减量,评估客观图像参数、主观图像质量及肿瘤学判读。中腹部SUVmean和噪声等效计数率下降较上腹部更明显,主观图像质量在1.25–2.75 MBq/kgBW范围内稳定。2 MBq/kgBW时90个病灶中86个被正确识别,Likert评分无显著差异;作者结论为肿瘤学全身检查剂量可能可降至2 MBq/kgBW,但目前不推荐成人低于3 MBq/kgBW。
要点
- 模拟减量至2 MBq/kgBW时,90个病灶中86个被正确识别,Likert评分与2 MBq/kgBW相比无显著差异。
- 中腹部SUVmean和噪声等效计数率随剂量下降的降低幅度大于上腹部(小肠SUVmean平均−45%,肝脏−15%)。
- 主观图像质量在1.25–2.75 MBq/kgBW范围内与2 MBq/kgBW相比稳定,但2例患者出现中腹部大面积放射性缺损区。
核心结论
- 18F-FDG PET/MRI剂量在肿瘤学全身检查中可能可降至2 MBq/kgBW。
- 中腹部图像质量似乎比上腹部更受低剂量影响,单例中可出现大面积放射性缺损区。
- 作者目前不推荐成人剂量低于3 MBq/kgBW。
研究设计与样本
- 回顾性模拟研究,纳入19例接受全身18F-FDG PET/MRI检查的患者,平均年龄50.9±11.7岁,平均体重指数22.8±3.2 kg/m2。
- 模拟剂量从3 MBq/kgBW阶梯减至0.5 MBq/kgBW,间隔0.25。
主要发现
- 随着剂量降低,中腹部区域SUVmean和噪声等效计数率下降幅度大于上腹部(小肠和肝脏SUVmean平均分别下降45%和15%)。
- 变异系数呈非线性增加,在低于1.5 MBq/kgBW时更为明显。
- 与2 MBq/kgBW相比,主观图像质量在1.25–2.75 MBq/kgBW范围内保持稳定,但2例患者观察到中腹部大面积放射性缺损区。
- PERCIST判读中,所有病例的目标病灶在剂量降至2 MBq/kgBW时仍高于肝脏阈值且SUVpeak稳定。
- 2 MBq/kgBW剂量下90个病灶中86个被正确识别,Likert评分无显著差异。
关键数值与推荐
- 模拟剂量范围为3至0.5 MBq/kgBW,间隔0.25。
- 主观图像质量以2 MBq/kgBW为参考进行比较。
- 肿瘤学判读采用PERCIST,并以2 MBq/kgBW和最大剂量图像定义恶性病灶作为金标准。
- 病灶诊断置信度采用Likert量表测量。
临床怎么用
- 作者不推荐目前将成人18F-FDG PET/MRI剂量降至3 MBq/kgBW以下。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The aim of our study was to evaluate the effect of stepwise-reduced doses on objective and subjective image parameters and on oncologic readings in whole-body 18F-FDG PET/MRI. Methods: We retrospectively simulated the stepwise reduction of 18F-FDG doses of 19 patients (mean age ± SD, 50.9 ± 11.7 y; mean body mass index ± SD, 22.8 ± 3.2 kg/m2) who received a whole-body PET/MRI examination from 3 to 0.5 MBq/kg of body weight (kgBW) in intervals of 0.25. Objective imaging parameters were assessed by measuring the SUV and coefficient of variation in different regions (aorta, liver, spleen, kidney, small bowel, lumbar vertebra, psoas muscle, urinary bladder) as well as the noise-equivalent counting rates in each bed position. Subjective image quality was evaluated with a masked reading of each simulated PET compared with the dose of 2 MBq/kgBW. Oncologic reading was performed first according to PERCIST in each dose and second by defining malignant lesions in doses of 2 MBq/kgBW and the maximum dose image (gold standard). The diagnostic confidence of each lesion was measured using a Likert scale. Results: With decreasing doses, regions in the mid abdomen showed a stronger decrease of SUVmean and noise-equivalent counting rates than regions in the upper abdomen (SUVmean, -45% and -15% on average in the small bowel and the liver, respectively). The coefficient of variation showed a nonlinear increase, pronounced below 1.5 MBq/kgBW. Subjective image quality was stable over a range between 1.25 and 2.75 MBq/kgBW compared with 2 MBq/kgBW. However, large photopenic areas in the mid abdomen were observed in 2 patients. In the PERCIST reading, target lesions were above the liver threshold with a stable SUVpeak in all cases down to 2 MBq/kgBW. Eighty-six of 90 lesions were identified correctly with a dose of 2 MBq/kgBW; Likert scores did not differ significantly. Conclusion: A reduction of doses in 18F-FDG PET/MRI might be possible down to 2 MBq/kgBW in oncologic whole-body examinations. The image quality in the mid abdomen seems to be more affected by lower doses than in the upper abdomen, and in single cases large photopenic areas can occur. Therefore, we do not recommend reducing doses below 3 MBq/kgBW in adults at this time.
引用
- Seith F, Schmidt H, Kunz J, et al. Simulation of Tracer Dose Reduction in 18F-FDG PET/MRI: Effects on Oncologic Reading, Image Quality, and Artifacts. J Nucl Med. 2017. PMID: 28360205. doi:10.2967/jnumed.116.184440
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。